Table 1.
| |||||
---|---|---|---|---|---|
MIC50 (μM)
|
|||||
Compound | R | BioA-UEa | BioA-OEb | WT-biotinc | WT+biotind |
6 | 0.4 (1.7)e | 31.1 (>50)e | 5.6 (23.4)e | >50 (>50)e | |
7 | 10.4 | >50 | >50 | >50 | |
8 | 21.1 | >50 | >50 | >50 | |
9 | 1.9 | 17.7 | 10.2 | 10.7 | |
10 | >50 | >50 | >50 | >50 | |
11 | 18.3 | >50 | 28.6 | 39.1 | |
12 | 0.5 | 7.5 | 5.1 | 30.1 | |
13 | >50 | >50 | >50 | >50 | |
14 | 14.6 | >50 | >50 | >50 | |
15 | >50 | >50 | >50 | >50 | |
16 | 11.3 | >50 | >50 | >50 | |
17 | >50 | >50 | >50 | >50 | |
18 | >50 | >50 | >50 | >50 | |
19 | 10.6 | 47.6 | 8.7 | 6.2 | |
20 | >50 | >50 | >50 | >50 |
Minimum inhibitory concentration (MIC) that results in 50% inhibition against the Mtb BioA underexpression strain.
MIC that results in 50% inhibition against the Mtb BioA overexpression strain.
MIC that results in 50% inhibition against Mtb H37Rv without supplemental biotin.
MIC that results in 50% inhibition against Mtb H37Rv with 1 μM supplemental biotin.
MIC that results in 90% inhibition.